|
|
Expert in Pharmacoepidemiology, Pharmacoeconomics, Epidemiology, FDA, Drugs, Education
Available for your Consulting and Expert Witness Needs
|
|
|
|
Summary of Expertise:
|
Listed with other top experts in: |
|
Expert is one of the leaders in the field of pharmacoepidemiology. He has extensive experience consulting on issues of applying epidemiological principles to the risk/benefit assessment of drugs.
|
|
|
As Director of Global Pharmacoepidemiology and Health Economics Research for a major pharmaceutical company, he initiated a program to integrate epidemiologic and health economic considerations in to the entire drug development cycle.
|
|
|
He has experience addressing FDA and other regulatory agency regulations for reporting potential adverse reactions to marketed drugs and for reporting possible safety issues during the drug development process.
|
|
|
He founded the major international society in pharamcoepidemiology and served as its Executive Director for 15 years. He has traveled extensively to many of the 53 countries represented in the society and currently works with collaborators in Europe, Australia, Africa, and Asia. He has particular interests in projects in China and holds an Adjunct Professorship at the Medical School in Tianjin.
|
|
|
He Chairs the Quality Improvement Committee for a major community hospital and partners with a physician who specializes in industry quality management.
|
|
|
|
|
Show Secondary and Basic Areas of Expertise | Localities: Expert may consult nationally and internationally, and is also local to the following cities: Kansas City, Missouri;
Independence, Missouri;
Saint Joseph, Missouri;
Lees Summit, Missouri;
Kansas City, Kansas;
Topeka, Kansas;
Olathe, Kansas;
and Lawrence, Kansas.
|
| Year |
|
Degree |
|
Subject |
|
Institution |
|
|
1974
|
|
Ph.D.
|
|
Epidemiology
|
|
University of California - Berkeley
|
|
|
1968
|
|
M.A.
|
|
Mathematical Statistics
|
|
University of Missouri
|
|
|
1966
|
|
M.S.
|
|
Public Health
|
|
University of Missouri
|
|
|
1962
|
|
B.S.
|
|
Mathematics
|
|
University of Maryland
|
|
| Years |
|
Employer |
|
Department |
|
Title |
|
Responsibilities |
|
1991 to
|
|
(Undisclosed University)
|
|
Preventive Medicine
|
|
Professor
|
|
Expert's responsibility includes teaching epidemiology and pharmacoepidemiology, advising and supervising graduate students, and research.
|
|
1987 to 1991
|
|
Hoechst Marion Roussel
|
|
Global Pharmacoepidemiology and Health Economics Research
|
|
Director
|
|
He established and directed the global postmarketing safety department responsible for providing epidemiologic and health economic support to company products.
|
|
1981 to 1983
|
|
Bureau of Drugs, FDA
|
|
Epidemiology Development Branch
|
|
Director
|
|
He directed the program which developed epidemiologic approaches to studying postmarketing drug safety.
|
|
1968 to 1981
|
|
United States Public Health Service - SF
|
|
Division of Hospital and Clinics
|
|
Associate Chief Research Coord. Br, Chief Clinical Research
|
|
He managed the peer review system of clinics and IRBs which distributed $6-$8 million/year in intramural funding. He also directed the coordinating center for two large multi-center clinical trials.
|
Associations/Societies
Expert is a member of ISPE, ACE, SER, APHA, and the American Society of Suicidology.
|
Professional Appointments
He is a Lifetime Board Member of ISPE and is the Chair of the Global Devleopment Committee of ISPE. He serves on the Board of Governors for the Truman Medical Center. He is also the Chair of the Joint Quality Committee for Truman Medical Center.
|
Awards/Recognition
Expert is the Founder and Incorporator of the International Society for Pharmacoepidemiology. The annual "Expert" scholarship awarded by ISPE is given in his honor.
|
| Publications: |
 |
Publications and Patents Summary
He has over 40 publications in peer reviewed journals, has edited one book and has written several book chapters.
|
| Selected Consulting Examples: |
-
Expert spent a year directing the development of a pharmacoeconomics outcomes research business for a major CRO. He commuted monthly for onsite interactions and client visits.
|
|
Click the green button above to contact
Expert for a free initial screening call regarding your expert consulting needs.
Expert is available for consulting to corporate, legal and government clients.
Remember, your initial screening call to speak with
Expert is free.
|
|
Expert Witness Experience Summary:
|
|
Expert has served as an expert for legal firms in several states and as a "friend of the court."
|
|
Recent Litigation Client Requests:
|
-
FDA expert witness for consulting on an atypical antipsychotic..
|
|
Click the green button above to contact
Expert for a free initial screening call regarding expert testimony,
litigation consulting and support, forensic services, or any related expert witness services.
A few litigation needs include product liability, personal injury, economic loss, intellectual property
(patent, trademark, trade secret, copyright), and insurance matters. Remember, your initial screening
call to speak with
Expert is free.
|
| Language Skills: |
 |
| Foreign Language |
|
Description |
|
German
|
|
He currently has low levels of German fluency, but at one time spoke fluently.
|
He has extensive international experience and contacts in the pharmaceutical industry, regulatory agencies and academia.
Click the green button above to contact
Expert for a free initial screening call regarding your marketing research, industry research, and company
research needs. For research needs involving multiple experts or secondary research,
a Research Director can be assigned to coordinate the work into a custom report for you as a potentially quicker
and more cost effective alternative to doing this work yourself or hiring a boutique consultancy.
Remember, your initial screening call to speak with
Expert is free.
|
| Additional Skills and Services: |
 |
Training/Seminars
He developed and managed over 30 international meetings and conferences, with from 50 to 650 participants.
|
Other Skills and Services
He has conducted extensive travel and collaboration in Europe, and has had several lecture visits to Japan and China.
|
|